Evidence map›Paper›PMID 42677148›Full record

ArticleBrain communications2026

A vascular component to the selective vulnerability of the medial temporal lobe to tau pathology.

Vincent Doyon, Félix Janelle, Monica Sean, Davy Vanderweyen, Samantha Côté, Julia Huck, Pascal Tétreault, Jean-François Lepage, Jose Gutierrez, Christian Bocti and 3 more

Abstract read
In one paragraph

Article in Brain communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vincent DoyonDepartment of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.
Félix JanelleDepartment of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.
Monica SeanDepartment of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.
Davy VanderweyenDepartment of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.
Samantha CôtéDepartment of Psychology, Bishop's University, Sherbrooke J1M 1Z7, Canada.
Julia HuckDepartment of Radiology, University of Calgary, Calgary T2N 1N4, Canada.
Pascal TétreaultDepartment of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.
Jean-François LepageDepartment of Pediatrics, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.ORCID https://orcid.org/0000-0002-1181-6043
Jose GutierrezDepartment of Neurology, University of Miami Miller School of Medicine, Miami 33136, USA.
Christian BoctiDepartment of Medicine, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.
Tamàs FülöpDepartment of Medicine, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.
Alexa Pichet-BinetteDepartment of Pharmacology and Physiology, Université de Montréal, Montréal H3T 1J4, Canada.
Kevin WhittingstallDepartment of Medical Imaging and Radiation Sciences, Université de Sherbrooke, Sherbrooke J1H 5N4, Canada.

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5M
The natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 2005 to 2025
$49.5M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
THE XNAT IMAGING INFORMATICS PLATFORMR01EB009352 · NIBIB · WASHINGTON UNIVERSITY · PI Daniel Scott Marcus · 2009 to 2026
$9.3M
DRIVING PERFORMANCE IN PRECLINICAL ALZHEIMER'S DISEASER01AG043434 · NIA · WASHINGTON UNIVERSITY · PI ROE, CATHERINE M · 2012 to 2016
$2.4M
NCATS NIH HHS UL1 TR000448NCATS NIH HHS UL1 TR002345NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS R01 AG043434NIBIB NIH HHS R01 EB009352
6 · The paper itself

Abstract

The medial temporal lobe is widely recognized as an early site of pathological tau deposition, a central feature in the development of cognitive symptoms. As of now, the biological mechanisms underlying this selective vulnerability of the medial temporal lobe are not yet understood. Here, we tested whether alterations in medial temporal lobe arterial structure are associated with early tau accumulation and cognitive decline. We first applied a novel imaging methodology (super-selective arterial spin labelling) to map vascular supply to the medial temporal lobe. Next, we cross-sectionally investigated the relationship between medial temporal lobe artery diameters and tau burden, derived from magnetic resonance angiography and positron emission tomography imaging, in 151 cognitively unimpaired individuals (mean age: 67.6 years old). Finally, we examined whether artery diameter was correlated with the rate of cognitive decline in a separate cohort of 43 individuals (mean age: 74.2 years old). We found that the blood supply to the medial temporal lobe depended more on arteries from the anterior circulation than the posterior circulation. Individuals with small anterior choroidal artery diameters tended to show higher medial temporal lobe tau burden (r = -0.26,

Indexed as

agingAlzheimer’s diseasebrain arterycircle of Willisvascular

Identifiers

PMID42677148
PMCPMC13527872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.